nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—KCNH2—Loratadine—asthma	0.0328	0.0499	CbGbCtD
Ondansetron—CYP3A7—Salmeterol—asthma	0.0292	0.0444	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Salmeterol—asthma	0.0292	0.0444	CbGbCtD
Ondansetron—CYP3A7—Fluticasone Propionate—asthma	0.0248	0.0377	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Fluticasone Propionate—asthma	0.0248	0.0377	CbGbCtD
Ondansetron—CYP2E1—Zafirlukast—asthma	0.0221	0.0336	CbGbCtD
Ondansetron—CYP3A5—Beclomethasone—asthma	0.0219	0.0333	CbGbCtD
Ondansetron—CYP3A5—Salmeterol—asthma	0.0219	0.0333	CbGbCtD
Ondansetron—CYP3A5—Fluticasone Propionate—asthma	0.0186	0.0283	CbGbCtD
Ondansetron—CYP2E1—Aminophylline—asthma	0.0182	0.0276	CbGbCtD
Ondansetron—CYP2E1—Theophylline—asthma	0.0171	0.026	CbGbCtD
Ondansetron—CYP1A2—Zileuton—asthma	0.0145	0.0221	CbGbCtD
Ondansetron—CYP2D6—Ciclesonide—asthma	0.0145	0.022	CbGbCtD
Ondansetron—CYP2C9—Zileuton—asthma	0.0131	0.0199	CbGbCtD
Ondansetron—CYP1A2—Zafirlukast—asthma	0.0128	0.0194	CbGbCtD
Ondansetron—CYP2D6—Ipratropium bromide—asthma	0.012	0.0182	CbGbCtD
Ondansetron—CYP2C9—Zafirlukast—asthma	0.0115	0.0175	CbGbCtD
Ondansetron—CYP3A4—Fluticasone furoate—asthma	0.0113	0.0171	CbGbCtD
Ondansetron—CYP2C9—Arformoterol—asthma	0.0111	0.0169	CbGbCtD
Ondansetron—CYP2C9—Formoterol—asthma	0.0111	0.0169	CbGbCtD
Ondansetron—CYP2D6—Zafirlukast—asthma	0.0105	0.016	CbGbCtD
Ondansetron—CYP1A2—Aminophylline—asthma	0.0105	0.016	CbGbCtD
Ondansetron—CYP2D6—Arformoterol—asthma	0.0102	0.0155	CbGbCtD
Ondansetron—CYP2D6—Formoterol—asthma	0.0102	0.0155	CbGbCtD
Ondansetron—CYP3A4—Budesonide—asthma	0.0101	0.0153	CbGbCtD
Ondansetron—CYP1A2—Theophylline—asthma	0.00988	0.015	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Hydrocortisone—asthma	0.00933	0.0142	CbGbCtD
Ondansetron—CYP3A7—Hydrocortisone—asthma	0.00933	0.0142	CbGbCtD
Ondansetron—CYP3A4—Ciclesonide—asthma	0.00919	0.014	CbGbCtD
Ondansetron—CYP3A4—Indacaterol—asthma	0.00919	0.014	CbGbCtD
Ondansetron—CYP2D6—Tiotropium—asthma	0.00908	0.0138	CbGbCtD
Ondansetron—CYP2C9—Theophylline—asthma	0.0089	0.0135	CbGbCtD
Ondansetron—CYP3A4—Salmeterol—asthma	0.00855	0.013	CbGbCtD
Ondansetron—CYP3A4—Salbutamol—asthma	0.00855	0.013	CbGbCtD
Ondansetron—CYP3A4—Flunisolide—asthma	0.00855	0.013	CbGbCtD
Ondansetron—CYP2C9—Loratadine—asthma	0.00844	0.0128	CbGbCtD
Ondansetron—CYP2C9—Montelukast—asthma	0.00844	0.0128	CbGbCtD
Ondansetron—CYP2D6—Theophylline—asthma	0.00814	0.0124	CbGbCtD
Ondansetron—CYP2D6—Loratadine—asthma	0.00772	0.0117	CbGbCtD
Ondansetron—CYP3A4—Ipratropium bromide—asthma	0.00762	0.0116	CbGbCtD
Ondansetron—CYP3A4—Zileuton—asthma	0.00762	0.0116	CbGbCtD
Ondansetron—CYP3A4—Fluticasone Propionate—asthma	0.00727	0.011	CbGbCtD
Ondansetron—CYP3A5—Hydrocortisone—asthma	0.007	0.0106	CbGbCtD
Ondansetron—CYP3A4—Zafirlukast—asthma	0.00671	0.0102	CbGbCtD
Ondansetron—CYP3A7—Dexamethasone—asthma	0.0058	0.00882	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Dexamethasone—asthma	0.0058	0.00882	CbGbCtD
Ondansetron—CYP3A4—Tiotropium—asthma	0.00577	0.00877	CbGbCtD
Ondansetron—CYP2E1—Dexamethasone—asthma	0.0056	0.00851	CbGbCtD
Ondansetron—CYP3A4—Aminophylline—asthma	0.00551	0.00837	CbGbCtD
Ondansetron—CYP3A4—Theophylline—asthma	0.00518	0.00787	CbGbCtD
Ondansetron—CYP3A4—Loratadine—asthma	0.00491	0.00746	CbGbCtD
Ondansetron—CYP3A4—Montelukast—asthma	0.00491	0.00746	CbGbCtD
Ondansetron—HTR3A—vagus nerve—asthma	0.00478	0.279	CbGeAlD
Ondansetron—CYP3A4—Methylprednisolone—asthma	0.00449	0.00682	CbGbCtD
Ondansetron—CYP3A5—Dexamethasone—asthma	0.00435	0.00662	CbGbCtD
Ondansetron—CYP3A4—Triamcinolone—asthma	0.0034	0.00517	CbGbCtD
Ondansetron—CYP2C9—Dexamethasone—asthma	0.00292	0.00444	CbGbCtD
Ondansetron—CYP3A4—Betamethasone—asthma	0.00292	0.00444	CbGbCtD
Ondansetron—CYP3A4—Prednisolone—asthma	0.00288	0.00438	CbGbCtD
Ondansetron—CYP3A4—Hydrocortisone—asthma	0.00273	0.00415	CbGbCtD
Ondansetron—CYP3A4—Prednisone—asthma	0.00272	0.00413	CbGbCtD
Ondansetron—CYP2D6—Dexamethasone—asthma	0.00267	0.00406	CbGbCtD
Ondansetron—HTR4—adrenal cortex—asthma	0.00266	0.155	CbGeAlD
Ondansetron—HTR4—adrenal gland—asthma	0.00192	0.112	CbGeAlD
Ondansetron—CYP3A4—Dexamethasone—asthma	0.0017	0.00258	CbGbCtD
Ondansetron—HTR3A—respiratory system—asthma	0.000854	0.0498	CbGeAlD
Ondansetron—SLC47A1—adrenal cortex—asthma	0.000704	0.041	CbGeAlD
Ondansetron—HTR1B—cardiovascular system—asthma	0.000549	0.032	CbGeAlD
Ondansetron—SLC47A1—adrenal gland—asthma	0.000508	0.0296	CbGeAlD
Ondansetron—HTR3A—lung—asthma	0.000454	0.0264	CbGeAlD
Ondansetron—SLC47A1—lung—asthma	0.000446	0.026	CbGeAlD
Ondansetron—HTR1A—cardiovascular system—asthma	0.000443	0.0258	CbGeAlD
Ondansetron—CYP1A2—respiratory system—asthma	0.000441	0.0257	CbGeAlD
Ondansetron—CYP3A5—respiratory system—asthma	0.000425	0.0248	CbGeAlD
Ondansetron—CYP2E1—respiratory system—asthma	0.000397	0.0231	CbGeAlD
Ondansetron—KCNH2—cardiovascular system—asthma	0.000394	0.023	CbGeAlD
Ondansetron—HTR1A—adrenal gland—asthma	0.00035	0.0204	CbGeAlD
Ondansetron—CYP2C9—cardiovascular system—asthma	0.000321	0.0187	CbGeAlD
Ondansetron—KCNH2—adrenal gland—asthma	0.000312	0.0182	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—asthma	0.000304	0.0177	CbGeAlD
Ondansetron—CYP2E1—adrenal gland—asthma	0.00024	0.014	CbGeAlD
Ondansetron—CYP1A2—lung—asthma	0.000234	0.0136	CbGeAlD
Ondansetron—CYP3A5—lung—asthma	0.000226	0.0132	CbGeAlD
Ondansetron—CYP2E1—lung—asthma	0.000211	0.0123	CbGeAlD
Ondansetron—Rash—Formoterol—asthma	6.99e-05	0.000311	CcSEcCtD
Ondansetron—Rash—Arformoterol—asthma	6.99e-05	0.000311	CcSEcCtD
Ondansetron—Mediastinal disorder—Methylprednisolone—asthma	6.99e-05	0.000311	CcSEcCtD
Ondansetron—Dermatitis—Arformoterol—asthma	6.98e-05	0.000311	CcSEcCtD
Ondansetron—Dermatitis—Formoterol—asthma	6.98e-05	0.000311	CcSEcCtD
Ondansetron—Headache—Arformoterol—asthma	6.94e-05	0.000309	CcSEcCtD
Ondansetron—Headache—Formoterol—asthma	6.94e-05	0.000309	CcSEcCtD
Ondansetron—Arrhythmia—Triamcinolone—asthma	6.94e-05	0.000309	CcSEcCtD
Ondansetron—Diarrhoea—Budesonide—asthma	6.93e-05	0.000309	CcSEcCtD
Ondansetron—Vision blurred—Prednisolone—asthma	6.93e-05	0.000309	CcSEcCtD
Ondansetron—Arrhythmia—Methylprednisolone—asthma	6.92e-05	0.000309	CcSEcCtD
Ondansetron—Dizziness—Salbutamol—asthma	6.92e-05	0.000308	CcSEcCtD
Ondansetron—Vomiting—Montelukast—asthma	6.9e-05	0.000307	CcSEcCtD
Ondansetron—Rash—Montelukast—asthma	6.84e-05	0.000305	CcSEcCtD
Ondansetron—Dermatitis—Montelukast—asthma	6.84e-05	0.000305	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisolone—asthma	6.82e-05	0.000304	CcSEcCtD
Ondansetron—Headache—Montelukast—asthma	6.8e-05	0.000303	CcSEcCtD
Ondansetron—Visual impairment—Betamethasone—asthma	6.79e-05	0.000303	CcSEcCtD
Ondansetron—Visual impairment—Dexamethasone—asthma	6.79e-05	0.000303	CcSEcCtD
Ondansetron—Erythema—Triamcinolone—asthma	6.76e-05	0.000301	CcSEcCtD
Ondansetron—Erythema—Methylprednisolone—asthma	6.75e-05	0.000301	CcSEcCtD
Ondansetron—Acute coronary syndrome—Prednisone—asthma	6.74e-05	0.0003	CcSEcCtD
Ondansetron—Angioedema—Prednisolone—asthma	6.72e-05	0.000299	CcSEcCtD
Ondansetron—Myocardial infarction—Prednisone—asthma	6.7e-05	0.000299	CcSEcCtD
Ondansetron—Dizziness—Budesonide—asthma	6.7e-05	0.000299	CcSEcCtD
Ondansetron—Ill-defined disorder—Hydrocortisone—asthma	6.66e-05	0.000297	CcSEcCtD
Ondansetron—Vomiting—Salbutamol—asthma	6.65e-05	0.000296	CcSEcCtD
Ondansetron—Malaise—Prednisolone—asthma	6.63e-05	0.000295	CcSEcCtD
Ondansetron—Rash—Salbutamol—asthma	6.6e-05	0.000294	CcSEcCtD
Ondansetron—Syncope—Prednisolone—asthma	6.59e-05	0.000294	CcSEcCtD
Ondansetron—Dermatitis—Salbutamol—asthma	6.59e-05	0.000294	CcSEcCtD
Ondansetron—Eye disorder—Betamethasone—asthma	6.59e-05	0.000293	CcSEcCtD
Ondansetron—Eye disorder—Dexamethasone—asthma	6.59e-05	0.000293	CcSEcCtD
Ondansetron—Angioedema—Hydrocortisone—asthma	6.56e-05	0.000292	CcSEcCtD
Ondansetron—Headache—Salbutamol—asthma	6.55e-05	0.000292	CcSEcCtD
Ondansetron—Malaise—Hydrocortisone—asthma	6.48e-05	0.000289	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisolone—asthma	6.46e-05	0.000288	CcSEcCtD
Ondansetron—Vomiting—Budesonide—asthma	6.44e-05	0.000287	CcSEcCtD
Ondansetron—Syncope—Hydrocortisone—asthma	6.44e-05	0.000287	CcSEcCtD
Ondansetron—Angiopathy—Dexamethasone—asthma	6.39e-05	0.000285	CcSEcCtD
Ondansetron—Angiopathy—Betamethasone—asthma	6.39e-05	0.000285	CcSEcCtD
Ondansetron—Rash—Budesonide—asthma	6.39e-05	0.000285	CcSEcCtD
Ondansetron—Dermatitis—Budesonide—asthma	6.38e-05	0.000284	CcSEcCtD
Ondansetron—Convulsion—Prednisolone—asthma	6.37e-05	0.000284	CcSEcCtD
Ondansetron—Headache—Budesonide—asthma	6.35e-05	0.000283	CcSEcCtD
Ondansetron—Loss of consciousness—Hydrocortisone—asthma	6.31e-05	0.000281	CcSEcCtD
Ondansetron—Arrhythmia—Dexamethasone—asthma	6.3e-05	0.000281	CcSEcCtD
Ondansetron—Arrhythmia—Betamethasone—asthma	6.3e-05	0.000281	CcSEcCtD
Ondansetron—Ill-defined disorder—Triamcinolone—asthma	6.27e-05	0.00028	CcSEcCtD
Ondansetron—Ill-defined disorder—Methylprednisolone—asthma	6.26e-05	0.000279	CcSEcCtD
Ondansetron—Bradycardia—Prednisone—asthma	6.25e-05	0.000278	CcSEcCtD
Ondansetron—Convulsion—Hydrocortisone—asthma	6.22e-05	0.000277	CcSEcCtD
Ondansetron—Discomfort—Prednisolone—asthma	6.19e-05	0.000276	CcSEcCtD
Ondansetron—Angioedema—Triamcinolone—asthma	6.18e-05	0.000275	CcSEcCtD
Ondansetron—Haemoglobin—Prednisone—asthma	6.17e-05	0.000275	CcSEcCtD
Ondansetron—Angioedema—Methylprednisolone—asthma	6.16e-05	0.000275	CcSEcCtD
Ondansetron—Haemorrhage—Prednisone—asthma	6.14e-05	0.000274	CcSEcCtD
Ondansetron—Erythema—Dexamethasone—asthma	6.14e-05	0.000273	CcSEcCtD
Ondansetron—Erythema—Betamethasone—asthma	6.14e-05	0.000273	CcSEcCtD
Ondansetron—Malaise—Triamcinolone—asthma	6.1e-05	0.000272	CcSEcCtD
Ondansetron—Anxiety—Hydrocortisone—asthma	6.09e-05	0.000271	CcSEcCtD
Ondansetron—Malaise—Methylprednisolone—asthma	6.08e-05	0.000271	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.07e-05	0.000271	CcSEcCtD
Ondansetron—Syncope—Triamcinolone—asthma	6.06e-05	0.00027	CcSEcCtD
Ondansetron—Syncope—Methylprednisolone—asthma	6.05e-05	0.00027	CcSEcCtD
Ondansetron—Discomfort—Hydrocortisone—asthma	6.04e-05	0.000269	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisolone—asthma	6e-05	0.000267	CcSEcCtD
Ondansetron—Loss of consciousness—Triamcinolone—asthma	5.94e-05	0.000265	CcSEcCtD
Ondansetron—Loss of consciousness—Methylprednisolone—asthma	5.93e-05	0.000264	CcSEcCtD
Ondansetron—Shock—Prednisolone—asthma	5.9e-05	0.000263	CcSEcCtD
Ondansetron—Cough—Triamcinolone—asthma	5.9e-05	0.000263	CcSEcCtD
Ondansetron—Anaphylactic shock—Hydrocortisone—asthma	5.86e-05	0.000261	CcSEcCtD
Ondansetron—Convulsion—Triamcinolone—asthma	5.86e-05	0.000261	CcSEcCtD
Ondansetron—Tachycardia—Prednisolone—asthma	5.86e-05	0.000261	CcSEcCtD
Ondansetron—Convulsion—Methylprednisolone—asthma	5.85e-05	0.00026	CcSEcCtD
Ondansetron—Shock—Hydrocortisone—asthma	5.77e-05	0.000257	CcSEcCtD
Ondansetron—Nervous system disorder—Hydrocortisone—asthma	5.75e-05	0.000256	CcSEcCtD
Ondansetron—Eye disorder—Prednisone—asthma	5.74e-05	0.000256	CcSEcCtD
Ondansetron—Anxiety—Methylprednisolone—asthma	5.72e-05	0.000255	CcSEcCtD
Ondansetron—Tachycardia—Hydrocortisone—asthma	5.72e-05	0.000255	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.7e-05	0.000254	CcSEcCtD
Ondansetron—Flushing—Prednisone—asthma	5.7e-05	0.000254	CcSEcCtD
Ondansetron—Skin disorder—Hydrocortisone—asthma	5.69e-05	0.000254	CcSEcCtD
Ondansetron—Ill-defined disorder—Betamethasone—asthma	5.69e-05	0.000254	CcSEcCtD
Ondansetron—Ill-defined disorder—Dexamethasone—asthma	5.69e-05	0.000254	CcSEcCtD
Ondansetron—Discomfort—Triamcinolone—asthma	5.69e-05	0.000253	CcSEcCtD
Ondansetron—Discomfort—Methylprednisolone—asthma	5.68e-05	0.000253	CcSEcCtD
Ondansetron—Dry mouth—Triamcinolone—asthma	5.63e-05	0.000251	CcSEcCtD
Ondansetron—Angioedema—Betamethasone—asthma	5.61e-05	0.00025	CcSEcCtD
Ondansetron—Angioedema—Dexamethasone—asthma	5.61e-05	0.00025	CcSEcCtD
Ondansetron—Angiopathy—Prednisone—asthma	5.57e-05	0.000248	CcSEcCtD
Ondansetron—Immune system disorder—Prednisone—asthma	5.54e-05	0.000247	CcSEcCtD
Ondansetron—Malaise—Betamethasone—asthma	5.53e-05	0.000247	CcSEcCtD
Ondansetron—Malaise—Dexamethasone—asthma	5.53e-05	0.000247	CcSEcCtD
Ondansetron—Anaphylactic shock—Triamcinolone—asthma	5.52e-05	0.000246	CcSEcCtD
Ondansetron—Anaphylactic shock—Methylprednisolone—asthma	5.51e-05	0.000245	CcSEcCtD
Ondansetron—Syncope—Betamethasone—asthma	5.5e-05	0.000245	CcSEcCtD
Ondansetron—Syncope—Dexamethasone—asthma	5.5e-05	0.000245	CcSEcCtD
Ondansetron—Arrhythmia—Prednisone—asthma	5.48e-05	0.000244	CcSEcCtD
Ondansetron—Hypotension—Hydrocortisone—asthma	5.48e-05	0.000244	CcSEcCtD
Ondansetron—Shock—Triamcinolone—asthma	5.43e-05	0.000242	CcSEcCtD
Ondansetron—Shock—Methylprednisolone—asthma	5.42e-05	0.000241	CcSEcCtD
Ondansetron—Nervous system disorder—Methylprednisolone—asthma	5.4e-05	0.000241	CcSEcCtD
Ondansetron—Loss of consciousness—Betamethasone—asthma	5.39e-05	0.00024	CcSEcCtD
Ondansetron—Loss of consciousness—Dexamethasone—asthma	5.39e-05	0.00024	CcSEcCtD
Ondansetron—Paraesthesia—Prednisolone—asthma	5.39e-05	0.00024	CcSEcCtD
Ondansetron—Tachycardia—Triamcinolone—asthma	5.39e-05	0.00024	CcSEcCtD
Ondansetron—Tachycardia—Methylprednisolone—asthma	5.37e-05	0.000239	CcSEcCtD
Ondansetron—Skin disorder—Methylprednisolone—asthma	5.35e-05	0.000238	CcSEcCtD
Ondansetron—Erythema—Prednisone—asthma	5.34e-05	0.000238	CcSEcCtD
Ondansetron—Convulsion—Betamethasone—asthma	5.32e-05	0.000237	CcSEcCtD
Ondansetron—Convulsion—Dexamethasone—asthma	5.32e-05	0.000237	CcSEcCtD
Ondansetron—Paraesthesia—Hydrocortisone—asthma	5.26e-05	0.000235	CcSEcCtD
Ondansetron—Anxiety—Dexamethasone—asthma	5.21e-05	0.000232	CcSEcCtD
Ondansetron—Anxiety—Betamethasone—asthma	5.21e-05	0.000232	CcSEcCtD
Ondansetron—Discomfort—Dexamethasone—asthma	5.16e-05	0.00023	CcSEcCtD
Ondansetron—Discomfort—Betamethasone—asthma	5.16e-05	0.00023	CcSEcCtD
Ondansetron—Hypotension—Methylprednisolone—asthma	5.15e-05	0.000229	CcSEcCtD
Ondansetron—Pain—Prednisolone—asthma	5.13e-05	0.000229	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Hydrocortisone—asthma	5.06e-05	0.000225	CcSEcCtD
Ondansetron—Fatigue—Hydrocortisone—asthma	5.05e-05	0.000225	CcSEcCtD
Ondansetron—Vision blurred—Prednisone—asthma	5.04e-05	0.000224	CcSEcCtD
Ondansetron—Pain—Hydrocortisone—asthma	5.01e-05	0.000223	CcSEcCtD
Ondansetron—Anaphylactic shock—Dexamethasone—asthma	5.01e-05	0.000223	CcSEcCtD
Ondansetron—Anaphylactic shock—Betamethasone—asthma	5.01e-05	0.000223	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisone—asthma	4.96e-05	0.000221	CcSEcCtD
Ondansetron—Paraesthesia—Triamcinolone—asthma	4.96e-05	0.000221	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisolone—asthma	4.95e-05	0.00022	CcSEcCtD
Ondansetron—Paraesthesia—Methylprednisolone—asthma	4.94e-05	0.00022	CcSEcCtD
Ondansetron—Shock—Dexamethasone—asthma	4.93e-05	0.00022	CcSEcCtD
Ondansetron—Shock—Betamethasone—asthma	4.93e-05	0.00022	CcSEcCtD
Ondansetron—Dyspnoea—Triamcinolone—asthma	4.92e-05	0.000219	CcSEcCtD
Ondansetron—Nervous system disorder—Betamethasone—asthma	4.91e-05	0.000219	CcSEcCtD
Ondansetron—Nervous system disorder—Dexamethasone—asthma	4.91e-05	0.000219	CcSEcCtD
Ondansetron—Agitation—Prednisone—asthma	4.91e-05	0.000219	CcSEcCtD
Ondansetron—Tachycardia—Dexamethasone—asthma	4.89e-05	0.000218	CcSEcCtD
Ondansetron—Tachycardia—Betamethasone—asthma	4.89e-05	0.000218	CcSEcCtD
Ondansetron—Angioedema—Prednisone—asthma	4.88e-05	0.000218	CcSEcCtD
Ondansetron—Feeling abnormal—Hydrocortisone—asthma	4.83e-05	0.000215	CcSEcCtD
Ondansetron—Malaise—Prednisone—asthma	4.82e-05	0.000215	CcSEcCtD
Ondansetron—Gastrointestinal pain—Hydrocortisone—asthma	4.79e-05	0.000214	CcSEcCtD
Ondansetron—Syncope—Prednisone—asthma	4.79e-05	0.000214	CcSEcCtD
Ondansetron—Urticaria—Prednisolone—asthma	4.77e-05	0.000212	CcSEcCtD
Ondansetron—Fatigue—Triamcinolone—asthma	4.76e-05	0.000212	CcSEcCtD
Ondansetron—Fatigue—Methylprednisolone—asthma	4.75e-05	0.000212	CcSEcCtD
Ondansetron—Pain—Triamcinolone—asthma	4.72e-05	0.00021	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisone—asthma	4.7e-05	0.000209	CcSEcCtD
Ondansetron—Hypotension—Betamethasone—asthma	4.68e-05	0.000208	CcSEcCtD
Ondansetron—Hypotension—Dexamethasone—asthma	4.68e-05	0.000208	CcSEcCtD
Ondansetron—Urticaria—Hydrocortisone—asthma	4.66e-05	0.000207	CcSEcCtD
Ondansetron—Body temperature increased—Hydrocortisone—asthma	4.63e-05	0.000206	CcSEcCtD
Ondansetron—Abdominal pain—Hydrocortisone—asthma	4.63e-05	0.000206	CcSEcCtD
Ondansetron—Convulsion—Prednisone—asthma	4.63e-05	0.000206	CcSEcCtD
Ondansetron—Feeling abnormal—Triamcinolone—asthma	4.55e-05	0.000203	CcSEcCtD
Ondansetron—Feeling abnormal—Methylprednisolone—asthma	4.54e-05	0.000202	CcSEcCtD
Ondansetron—Anxiety—Prednisone—asthma	4.53e-05	0.000202	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.52e-05	0.000201	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methylprednisolone—asthma	4.5e-05	0.000201	CcSEcCtD
Ondansetron—Paraesthesia—Dexamethasone—asthma	4.5e-05	0.0002	CcSEcCtD
Ondansetron—Paraesthesia—Betamethasone—asthma	4.5e-05	0.0002	CcSEcCtD
Ondansetron—Discomfort—Prednisone—asthma	4.49e-05	0.0002	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisolone—asthma	4.42e-05	0.000197	CcSEcCtD
Ondansetron—Urticaria—Triamcinolone—asthma	4.38e-05	0.000195	CcSEcCtD
Ondansetron—Urticaria—Methylprednisolone—asthma	4.37e-05	0.000195	CcSEcCtD
Ondansetron—Body temperature increased—Triamcinolone—asthma	4.36e-05	0.000194	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisone—asthma	4.36e-05	0.000194	CcSEcCtD
Ondansetron—Abdominal pain—Methylprednisolone—asthma	4.35e-05	0.000194	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Betamethasone—asthma	4.32e-05	0.000193	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Dexamethasone—asthma	4.32e-05	0.000193	CcSEcCtD
Ondansetron—Hypersensitivity—Hydrocortisone—asthma	4.32e-05	0.000192	CcSEcCtD
Ondansetron—Fatigue—Dexamethasone—asthma	4.32e-05	0.000192	CcSEcCtD
Ondansetron—Fatigue—Betamethasone—asthma	4.32e-05	0.000192	CcSEcCtD
Ondansetron—Shock—Prednisone—asthma	4.29e-05	0.000191	CcSEcCtD
Ondansetron—Pain—Dexamethasone—asthma	4.28e-05	0.000191	CcSEcCtD
Ondansetron—Pain—Betamethasone—asthma	4.28e-05	0.000191	CcSEcCtD
Ondansetron—Nervous system disorder—Prednisone—asthma	4.28e-05	0.000191	CcSEcCtD
Ondansetron—Tachycardia—Prednisone—asthma	4.26e-05	0.00019	CcSEcCtD
Ondansetron—Skin disorder—Prednisone—asthma	4.24e-05	0.000189	CcSEcCtD
Ondansetron—Asthenia—Hydrocortisone—asthma	4.21e-05	0.000187	CcSEcCtD
Ondansetron—Pruritus—Hydrocortisone—asthma	4.15e-05	0.000185	CcSEcCtD
Ondansetron—Feeling abnormal—Dexamethasone—asthma	4.13e-05	0.000184	CcSEcCtD
Ondansetron—Feeling abnormal—Betamethasone—asthma	4.13e-05	0.000184	CcSEcCtD
Ondansetron—Gastrointestinal pain—Betamethasone—asthma	4.09e-05	0.000182	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dexamethasone—asthma	4.09e-05	0.000182	CcSEcCtD
Ondansetron—Hypersensitivity—Triamcinolone—asthma	4.07e-05	0.000181	CcSEcCtD
Ondansetron—Hypersensitivity—Methylprednisolone—asthma	4.06e-05	0.000181	CcSEcCtD
Ondansetron—Diarrhoea—Hydrocortisone—asthma	4.01e-05	0.000179	CcSEcCtD
Ondansetron—Urticaria—Dexamethasone—asthma	3.98e-05	0.000177	CcSEcCtD
Ondansetron—Urticaria—Betamethasone—asthma	3.98e-05	0.000177	CcSEcCtD
Ondansetron—Dizziness—Prednisolone—asthma	3.97e-05	0.000177	CcSEcCtD
Ondansetron—Asthenia—Triamcinolone—asthma	3.96e-05	0.000176	CcSEcCtD
Ondansetron—Abdominal pain—Betamethasone—asthma	3.96e-05	0.000176	CcSEcCtD
Ondansetron—Body temperature increased—Betamethasone—asthma	3.96e-05	0.000176	CcSEcCtD
Ondansetron—Abdominal pain—Dexamethasone—asthma	3.96e-05	0.000176	CcSEcCtD
Ondansetron—Body temperature increased—Dexamethasone—asthma	3.96e-05	0.000176	CcSEcCtD
Ondansetron—Asthenia—Methylprednisolone—asthma	3.95e-05	0.000176	CcSEcCtD
Ondansetron—Paraesthesia—Prednisone—asthma	3.92e-05	0.000174	CcSEcCtD
Ondansetron—Pruritus—Triamcinolone—asthma	3.9e-05	0.000174	CcSEcCtD
Ondansetron—Pruritus—Methylprednisolone—asthma	3.9e-05	0.000174	CcSEcCtD
Ondansetron—Dizziness—Hydrocortisone—asthma	3.88e-05	0.000173	CcSEcCtD
Ondansetron—Rash—Prednisolone—asthma	3.78e-05	0.000169	CcSEcCtD
Ondansetron—Dermatitis—Prednisolone—asthma	3.78e-05	0.000168	CcSEcCtD
Ondansetron—Diarrhoea—Methylprednisolone—asthma	3.77e-05	0.000168	CcSEcCtD
Ondansetron—Fatigue—Prednisone—asthma	3.76e-05	0.000168	CcSEcCtD
Ondansetron—Headache—Prednisolone—asthma	3.76e-05	0.000168	CcSEcCtD
Ondansetron—Constipation—Prednisone—asthma	3.73e-05	0.000166	CcSEcCtD
Ondansetron—Vomiting—Hydrocortisone—asthma	3.73e-05	0.000166	CcSEcCtD
Ondansetron—Rash—Hydrocortisone—asthma	3.7e-05	0.000165	CcSEcCtD
Ondansetron—Dermatitis—Hydrocortisone—asthma	3.69e-05	0.000165	CcSEcCtD
Ondansetron—Headache—Hydrocortisone—asthma	3.67e-05	0.000164	CcSEcCtD
Ondansetron—Dizziness—Triamcinolone—asthma	3.65e-05	0.000163	CcSEcCtD
Ondansetron—Dizziness—Methylprednisolone—asthma	3.64e-05	0.000162	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisone—asthma	3.59e-05	0.00016	CcSEcCtD
Ondansetron—Asthenia—Dexamethasone—asthma	3.59e-05	0.00016	CcSEcCtD
Ondansetron—Asthenia—Betamethasone—asthma	3.59e-05	0.00016	CcSEcCtD
Ondansetron—Gastrointestinal pain—Prednisone—asthma	3.57e-05	0.000159	CcSEcCtD
Ondansetron—Pruritus—Dexamethasone—asthma	3.54e-05	0.000158	CcSEcCtD
Ondansetron—Pruritus—Betamethasone—asthma	3.54e-05	0.000158	CcSEcCtD
Ondansetron—Vomiting—Triamcinolone—asthma	3.51e-05	0.000156	CcSEcCtD
Ondansetron—Vomiting—Methylprednisolone—asthma	3.5e-05	0.000156	CcSEcCtD
Ondansetron—Rash—Triamcinolone—asthma	3.48e-05	0.000155	CcSEcCtD
Ondansetron—Dermatitis—Triamcinolone—asthma	3.48e-05	0.000155	CcSEcCtD
Ondansetron—Rash—Methylprednisolone—asthma	3.47e-05	0.000155	CcSEcCtD
Ondansetron—Dermatitis—Methylprednisolone—asthma	3.47e-05	0.000155	CcSEcCtD
Ondansetron—Urticaria—Prednisone—asthma	3.46e-05	0.000154	CcSEcCtD
Ondansetron—Headache—Triamcinolone—asthma	3.46e-05	0.000154	CcSEcCtD
Ondansetron—Headache—Methylprednisolone—asthma	3.45e-05	0.000154	CcSEcCtD
Ondansetron—Abdominal pain—Prednisone—asthma	3.45e-05	0.000154	CcSEcCtD
Ondansetron—Body temperature increased—Prednisone—asthma	3.45e-05	0.000154	CcSEcCtD
Ondansetron—Diarrhoea—Dexamethasone—asthma	3.43e-05	0.000153	CcSEcCtD
Ondansetron—Diarrhoea—Betamethasone—asthma	3.43e-05	0.000153	CcSEcCtD
Ondansetron—Dizziness—Dexamethasone—asthma	3.31e-05	0.000148	CcSEcCtD
Ondansetron—Dizziness—Betamethasone—asthma	3.31e-05	0.000148	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisone—asthma	3.21e-05	0.000143	CcSEcCtD
Ondansetron—Vomiting—Betamethasone—asthma	3.18e-05	0.000142	CcSEcCtD
Ondansetron—Vomiting—Dexamethasone—asthma	3.18e-05	0.000142	CcSEcCtD
Ondansetron—Rash—Dexamethasone—asthma	3.16e-05	0.000141	CcSEcCtD
Ondansetron—Rash—Betamethasone—asthma	3.16e-05	0.000141	CcSEcCtD
Ondansetron—Dermatitis—Betamethasone—asthma	3.15e-05	0.000141	CcSEcCtD
Ondansetron—Dermatitis—Dexamethasone—asthma	3.15e-05	0.000141	CcSEcCtD
Ondansetron—Headache—Betamethasone—asthma	3.14e-05	0.00014	CcSEcCtD
Ondansetron—Headache—Dexamethasone—asthma	3.14e-05	0.00014	CcSEcCtD
Ondansetron—Asthenia—Prednisone—asthma	3.13e-05	0.000139	CcSEcCtD
Ondansetron—Pruritus—Prednisone—asthma	3.09e-05	0.000137	CcSEcCtD
Ondansetron—Diarrhoea—Prednisone—asthma	2.98e-05	0.000133	CcSEcCtD
Ondansetron—Dizziness—Prednisone—asthma	2.88e-05	0.000128	CcSEcCtD
Ondansetron—Vomiting—Prednisone—asthma	2.77e-05	0.000124	CcSEcCtD
Ondansetron—Rash—Prednisone—asthma	2.75e-05	0.000123	CcSEcCtD
Ondansetron—Dermatitis—Prednisone—asthma	2.75e-05	0.000122	CcSEcCtD
Ondansetron—Headache—Prednisone—asthma	2.73e-05	0.000122	CcSEcCtD
Ondansetron—CYP2C9—Metabolism—ALOX5AP—asthma	8.64e-06	8.61e-05	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TGFB1—asthma	8.58e-06	8.56e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—HMOX1—asthma	8.57e-06	8.55e-05	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL2—asthma	8.57e-06	8.55e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADCY2—asthma	8.56e-06	8.53e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ITPR1—asthma	8.55e-06	8.53e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL3—asthma	8.53e-06	8.5e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SMAD3—asthma	8.47e-06	8.45e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CAT—asthma	8.46e-06	8.43e-05	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—EGFR—asthma	8.42e-06	8.39e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ITPR1—asthma	8.31e-06	8.29e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CHAT—asthma	8.31e-06	8.29e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CHAT—asthma	8.24e-06	8.22e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—RHOA—asthma	8.19e-06	8.16e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCL8—asthma	8.14e-06	8.12e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PPP2CA—asthma	8.1e-06	8.08e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KNG1—asthma	8.05e-06	8.02e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—asthma	8.02e-06	8e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AGTR1—asthma	8e-06	7.98e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PLA2G4A—asthma	7.99e-06	7.96e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GSTM1—asthma	7.99e-06	7.96e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR5—asthma	7.96e-06	7.93e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ARG1—asthma	7.93e-06	7.91e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CD86—asthma	7.92e-06	7.9e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCL8—asthma	7.91e-06	7.89e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EDN1—asthma	7.86e-06	7.83e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL2—asthma	7.85e-06	7.82e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2RA—asthma	7.84e-06	7.82e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6R—asthma	7.82e-06	7.8e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL10—asthma	7.82e-06	7.79e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.81e-06	7.79e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL5—asthma	7.79e-06	7.77e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL2—asthma	7.78e-06	7.76e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—RHOA—asthma	7.78e-06	7.76e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—C3—asthma	7.78e-06	7.75e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PLA2G4A—asthma	7.76e-06	7.74e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CSF2—asthma	7.68e-06	7.66e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NTRK1—asthma	7.67e-06	7.65e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADRB2—asthma	7.59e-06	7.57e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PDGFB—asthma	7.57e-06	7.55e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL2—asthma	7.56e-06	7.54e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NQO1—asthma	7.55e-06	7.53e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NQO1—asthma	7.53e-06	7.51e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SMAD3—asthma	7.47e-06	7.45e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALOX5—asthma	7.41e-06	7.39e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADCY2—asthma	7.39e-06	7.37e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALOX15—asthma	7.38e-06	7.36e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALOX5AP—asthma	7.38e-06	7.36e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADCY2—asthma	7.37e-06	7.35e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PPP2CA—asthma	7.36e-06	7.33e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALOX5—asthma	7.34e-06	7.32e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—LEP—asthma	7.24e-06	7.22e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCL8—asthma	7.19e-06	7.17e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ITPR1—asthma	7.18e-06	7.16e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDH7A1—asthma	7.17e-06	7.15e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PPP2CA—asthma	7.15e-06	7.13e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CARM1—asthma	7.07e-06	7.05e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—RHOA—asthma	7.07e-06	7.05e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CHAT—asthma	7.04e-06	7.02e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR5—asthma	7.02e-06	7e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CARM1—asthma	7.01e-06	6.99e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—DCN—asthma	6.97e-06	6.95e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2RA—asthma	6.92e-06	6.9e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—DCN—asthma	6.91e-06	6.89e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ARG2—asthma	6.87e-06	6.86e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL2—asthma	6.87e-06	6.85e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—C3—asthma	6.86e-06	6.84e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CD86—asthma	6.83e-06	6.82e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL8—asthma	6.83e-06	6.81e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FN1—asthma	6.83e-06	6.81e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EDN1—asthma	6.78e-06	6.76e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALDH2—asthma	6.78e-06	6.76e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL5—asthma	6.73e-06	6.71e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALDH2—asthma	6.72e-06	6.7e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PLA2G4A—asthma	6.7e-06	6.68e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PDGFB—asthma	6.68e-06	6.66e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CSF2—asthma	6.63e-06	6.61e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2—asthma	6.53e-06	6.51e-05	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—asthma	6.47e-06	6.45e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	6.46e-06	6.44e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SMAD3—asthma	6.45e-06	6.43e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTT1—asthma	6.44e-06	6.43e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTT1—asthma	6.39e-06	6.37e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—LEP—asthma	6.39e-06	6.37e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTP1—asthma	6.3e-06	6.28e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTP1—asthma	6.28e-06	6.26e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALOX5—asthma	6.28e-06	6.26e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—asthma	6.22e-06	6.2e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—HMOX1—asthma	6.21e-06	6.19e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL8—asthma	6.2e-06	6.19e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—HMOX1—asthma	6.2e-06	6.18e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ITPR1—asthma	6.19e-06	6.18e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ITPR1—asthma	6.18e-06	6.16e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PPP2CA—asthma	6.17e-06	6.16e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAT—asthma	6.13e-06	6.11e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAT—asthma	6.11e-06	6.1e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL2—asthma	6.08e-06	6.07e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6R—asthma	6.07e-06	6.05e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR5—asthma	6.06e-06	6.04e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FN1—asthma	6.02e-06	6.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CARM1—asthma	5.99e-06	5.97e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2RA—asthma	5.97e-06	5.96e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—EGFR—asthma	5.95e-06	5.94e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2—asthma	5.93e-06	5.91e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—C3—asthma	5.92e-06	5.91e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—DCN—asthma	5.9e-06	5.88e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	5.89e-06	5.87e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PLA2G4A—asthma	5.79e-06	5.77e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTM1—asthma	5.79e-06	5.77e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTM1—asthma	5.77e-06	5.76e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PLA2G4A—asthma	5.77e-06	5.76e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PDGFB—asthma	5.77e-06	5.75e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALDH2—asthma	5.74e-06	5.72e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALOX5AP—asthma	5.7e-06	5.68e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALOX15—asthma	5.7e-06	5.68e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SERPINE1—asthma	5.68e-06	5.66e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—asthma	5.64e-06	5.63e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	5.52e-06	5.5e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—LEP—asthma	5.51e-06	5.5e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—asthma	5.49e-06	5.47e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RHOA—asthma	5.48e-06	5.46e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTT1—asthma	5.46e-06	5.44e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CHAT—asthma	5.43e-06	5.42e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NOS3—asthma	5.42e-06	5.41e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL2—asthma	5.37e-06	5.35e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NQO1—asthma	5.36e-06	5.34e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6R—asthma	5.35e-06	5.34e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPP2CA—asthma	5.33e-06	5.31e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPP2CA—asthma	5.32e-06	5.3e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NQO1—asthma	5.31e-06	5.29e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—EGFR—asthma	5.25e-06	5.24e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADCY2—asthma	5.24e-06	5.23e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FN1—asthma	5.2e-06	5.19e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADCY2—asthma	5.2e-06	5.18e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.15e-06	5.14e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ALB—asthma	5.15e-06	5.13e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	5.03e-06	5.02e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SERPINE1—asthma	5.01e-06	5e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—NOS3—asthma	4.92e-06	4.91e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALOX5—asthma	4.84e-06	4.83e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RHOA—asthma	4.84e-06	4.82e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL8—asthma	4.81e-06	4.8e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NOS3—asthma	4.79e-06	4.77e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—asthma	4.74e-06	4.72e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL2—asthma	4.64e-06	4.62e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6R—asthma	4.62e-06	4.61e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CARM1—asthma	4.62e-06	4.61e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2—asthma	4.6e-06	4.58e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—asthma	4.57e-06	4.56e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—DCN—asthma	4.55e-06	4.54e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NQO1—asthma	4.54e-06	4.52e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EGFR—asthma	4.53e-06	4.52e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—asthma	4.5e-06	4.49e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	4.49e-06	4.48e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTP1—asthma	4.47e-06	4.45e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADCY2—asthma	4.44e-06	4.43e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDH2—asthma	4.43e-06	4.42e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTP1—asthma	4.43e-06	4.42e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMOX1—asthma	4.41e-06	4.39e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.4e-06	4.39e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ITPR1—asthma	4.4e-06	4.38e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMOX1—asthma	4.37e-06	4.36e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ITPR1—asthma	4.36e-06	4.35e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—asthma	4.35e-06	4.34e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAT—asthma	4.35e-06	4.33e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SERPINE1—asthma	4.33e-06	4.32e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTEN—asthma	4.33e-06	4.31e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAT—asthma	4.31e-06	4.3e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—asthma	4.25e-06	4.23e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTT1—asthma	4.21e-06	4.2e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RHOA—asthma	4.17e-06	4.16e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOS3—asthma	4.13e-06	4.12e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PLA2G4A—asthma	4.11e-06	4.09e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTM1—asthma	4.11e-06	4.09e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—asthma	4.09e-06	4.08e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—asthma	4.08e-06	4.07e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTM1—asthma	4.07e-06	4.06e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PLA2G4A—asthma	4.07e-06	4.06e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2—asthma	4.06e-06	4.05e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—asthma	4.04e-06	4.03e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTEN—asthma	3.93e-06	3.92e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—asthma	3.91e-06	3.9e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT3—asthma	3.87e-06	3.86e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—asthma	3.84e-06	3.83e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	3.84e-06	3.83e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTEN—asthma	3.82e-06	3.81e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTP1—asthma	3.78e-06	3.77e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPP2CA—asthma	3.78e-06	3.77e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPP2CA—asthma	3.75e-06	3.74e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMOX1—asthma	3.73e-06	3.72e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—asthma	3.73e-06	3.72e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ITPR1—asthma	3.72e-06	3.71e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—asthma	3.72e-06	3.71e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAT—asthma	3.68e-06	3.67e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—asthma	3.66e-06	3.65e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TGFB1—asthma	3.59e-06	3.58e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NOS3—asthma	3.57e-06	3.56e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NOS3—asthma	3.56e-06	3.55e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EGFR—asthma	3.52e-06	3.51e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2—asthma	3.5e-06	3.49e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NQO1—asthma	3.5e-06	3.49e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—asthma	3.48e-06	3.47e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PLA2G4A—asthma	3.48e-06	3.47e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTM1—asthma	3.48e-06	3.47e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—asthma	3.45e-06	3.44e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADCY2—asthma	3.43e-06	3.42e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT3—asthma	3.41e-06	3.4e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—asthma	3.31e-06	3.31e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTEN—asthma	3.3e-06	3.29e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—asthma	3.26e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—asthma	3.25e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPP2CA—asthma	3.2e-06	3.19e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TGFB1—asthma	3.16e-06	3.16e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EGFR—asthma	3.1e-06	3.09e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—asthma	2.98e-06	2.97e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT3—asthma	2.95e-06	2.94e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTP1—asthma	2.92e-06	2.91e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—asthma	2.9e-06	2.89e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMOX1—asthma	2.88e-06	2.87e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—asthma	2.88e-06	2.87e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ITPR1—asthma	2.87e-06	2.87e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTEN—asthma	2.84e-06	2.84e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAT—asthma	2.84e-06	2.83e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTEN—asthma	2.84e-06	2.83e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TGFB1—asthma	2.73e-06	2.72e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—asthma	2.7e-06	2.69e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLA2G4A—asthma	2.68e-06	2.68e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTM1—asthma	2.68e-06	2.68e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EGFR—asthma	2.68e-06	2.67e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—asthma	2.65e-06	2.64e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—asthma	2.62e-06	2.62e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NOS3—asthma	2.53e-06	2.52e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NOS3—asthma	2.51e-06	2.5e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPP2CA—asthma	2.47e-06	2.46e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—asthma	2.46e-06	2.45e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—asthma	2.38e-06	2.38e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—asthma	2.31e-06	2.31e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—asthma	2.29e-06	2.29e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—asthma	2.24e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NOS3—asthma	2.14e-06	2.14e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—asthma	2.06e-06	2.05e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTEN—asthma	2.02e-06	2.01e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTEN—asthma	2e-06	2e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—asthma	1.96e-06	1.96e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—asthma	1.9e-06	1.89e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—asthma	1.73e-06	1.72e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTEN—asthma	1.71e-06	1.71e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NOS3—asthma	1.65e-06	1.65e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—asthma	1.51e-06	1.51e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTEN—asthma	1.32e-06	1.32e-05	CbGpPWpGaD
